Skip to main content
Premium Trial:

Request an Annual Quote

Oxford University Buys Synapt HD Mass Spec From Waters

NEW YORK (GenomeWeb News) — Oxford University has purchased a mass spectrometer from Waters and plans to use it in joint studies with the Department of Medicine, Waters said today.
The company said the school's Department of Chemistry will use the Synapt HDMS system to study interactions between proteins and small molecules and bio-macromolecules.
The Chemistry and Medicine departments at Oxford will use the system to continue ongoing research on oxygen-sensitive enzymes that could be used to “starve cancerous tissues of oxygen” and possibly to restore damaged heart tissue.
Oxford professor Chris Schofield said the mass spectrometer will “enable us to study the effect of binding events on protein conformation in an efficient manner.”
The company said Schoefield also plans to use the tool to study protein complexes with multiple components.
Financial terms of the agreement were not released.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.